Briefing: Gene edit makes probiotic safer for immunocompromised patients
Strategic angle: An international team of researchers has modified a probiotic yeast to enhance safety for vulnerable populations.
Editorial Staff
1 min read
Updated 4 months ago
Modified yeast reduces infection risk for immunocompromised individuals.
Research conducted using animal models.
Target groups include older adults and infants.